Literature DB >> 30597122

The Zero-Sum Fallacy in Evidence Evaluation.

Toby D Pilditch1, Norman Fenton2, David Lagnado1.   

Abstract

There are many instances, both in professional domains such as law, forensics, and medicine and in everyday life, in which an effect (e.g., a piece of evidence or event) has multiple possible causes. In three experiments, we demonstrated that individuals erroneously assume that evidence that is equally predicted by two competing hypotheses offers no support for either hypothesis. However, this assumption holds only in cases in which competing causes are mutually exclusive and exhaustive (i.e., exactly one cause is true). We argue that this reasoning error is due to a zero-sum perspective on evidence, wherein people assume that evidence that supports one causal hypothesis must disconfirm its competitor. Thus, evidence cannot give positive support to both competitors. Across three experiments ( N = 49, N = 193, N = 201), we demonstrated that this error is robust to intervention and generalizes across several different contexts. We also ruled out several alternative explanations of the bias.

Entities:  

Keywords:  cognitive bias; evidential reasoning; intuitive judgment; open data; open materials; probabilistic reasoning; zero sum

Mesh:

Year:  2018        PMID: 30597122     DOI: 10.1177/0956797618818484

Source DB:  PubMed          Journal:  Psychol Sci        ISSN: 0956-7976


  2 in total

1.  Widening Access to Bayesian Problem Solving.

Authors:  Nicole Cruz; Saoirse Connor Desai; Stephen Dewitt; Ulrike Hahn; David Lagnado; Alice Liefgreen; Kirsty Phillips; Toby Pilditch; Marko Tešić
Journal:  Front Psychol       Date:  2020-04-09

2.  BARD: A Structured Technique for Group Elicitation of Bayesian Networks to Support Analytic Reasoning.

Authors:  Erik P Nyberg; Ann E Nicholson; Kevin B Korb; Michael Wybrow; Ingrid Zukerman; Steven Mascaro; Shreshth Thakur; Abraham Oshni Alvandi; Jeff Riley; Ross Pearson; Shane Morris; Matthieu Herrmann; A K M Azad; Fergus Bolger; Ulrike Hahn; David Lagnado
Journal:  Risk Anal       Date:  2021-06-19       Impact factor: 4.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.